HIV-1 Drug status | Mutations | Drug resistance | Useful drug options |
---|---|---|---|
NRTI | |||
Art after prophylaxis | M184 V | 3TC,FTC,DDI,ABC | AZT,TDF D4T |
M184 V,M41 L,T215Y | ABC,AZT,D4T,DDI, TDF,3TC,FTC | NONE | |
M184 V,M41 L,L74 V, T215Y | ABC,AZT,DDI, | 3TC,FTC | |
Art no prophylaxis | M184 V,D67G,M41 LM, K70R,K219E,T215I | 3TC,AZT,FTC,ABC, D4T,DDI,TDF | NONE |
M184 V | 3TC,FTC,DDI,ABC | AZT,TDF,D4T, | |
M184 V,Y115F,T215S | ABC,TDF | 3TC,FTC,DDI | |
Drug-naive | M184 V | 3TC,ABC,DDI,FTC | AZT,D4T,TDF |
L210 W | AZT,ABC,DDI,FTC, TDF | 3TC | |
NNRTI | |||
Art after prophylaxis | K103 N,Y181C | NVP,EFV,ETR,RPV | NONE |
A98G,K103 N,M230 LM | NVP,EFV,ETR,RPV | NONE | |
K103 N,M230 L,L100IL, A98G | NVP,EFV,ETR,RPV | NONE | |
Art no prophylaxis | A98G | NVP | EFV |
Drug-naive | K103 N | NVP,EFV | NONE |
V106A | NVP,EFV | NONE | |
E138A | NVP,EFV,ETR,RPV | NONE | |
A98G | NVP | EFV |